Related Experiment Video
Updated: May 21, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Vascular adenosine receptors; potential clinical applications
Ming-Fen Ho1, Roselyn B Rose'Meyer
1School of Medical Sciences, Griffith University, Gold Coast Campus, Queensland, Australia.
Adenosine, a metabolic sensor, impacts vascular functions like vasodilation and angiogenesis. Targeting its receptors (ADOR) offers therapeutic potential, but cross-species testing is crucial due to receptor distribution differences.
Area of Science:
- Biochemistry
- Physiology
- Pharmacology
Background:
- Adenosine is an endogenous purine nucleoside acting as a key metabolic sensor.
- It is released under hypoxic conditions, influencing vascular tissues.
- Adenosine plays roles in vasodilation, vessel remodeling, cell proliferation, and inflammatory responses.
Purpose of the Study:
- To explore the therapeutic potential of targeting adenosine receptor (ADOR) subtypes in vasculature.
- To highlight the importance of adenosine in physiological and pathological processes.
- To emphasize the necessity of cross-species testing for drug validation.
Main Methods:
- Review of existing literature on adenosine's role in vascular biology.
- Analysis of adenosine's involvement in conditions like wound healing and tumor growth.
- Discussion of current clinical applications and limitations of adenosine.
Main Results:
- Adenosine mediates diverse vascular effects, including stimulating vasculogenesis and angiogenesis.
- Targeting specific ADOR subtypes could offer therapeutic benefits for various pathological conditions.
- Significant differences in ADOR distribution across species necessitate careful validation.
Conclusions:
- Adenosine is a critical molecule in vascular homeostasis and disease.
- Selective modulation of ADOR subtypes presents a promising therapeutic strategy.
- Cross-species studies are essential for the successful translation of adenosine-targeting drugs.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...

